IGF1 and breast cancer: Cancer cells could dominate the IRS expression level to promote proliferation and survival, along with a response from IGF-1 and its downstream signal transducers, resulting in an elevated expression level of ERα in hormone-dependent BC, which converts to TNBC through the tumor progression sequence [51].